相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
Vanessa Monteil et al.
CELL (2020)
ST-Elevation Myocardial Infarction in Patients With COVID-19 Clinical and Angiographic Outcomes
Giulio G. Stefanini et al.
CIRCULATION (2020)
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
Luka Nicin et al.
EUROPEAN HEART JOURNAL (2020)
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
Gabriela M. Kuster et al.
EUROPEAN HEART JOURNAL (2020)
Postmortem examination of COVID-19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction
Thomas Menter et al.
HISTOPATHOLOGY (2020)
Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients
Pompilio Faggiano et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Complement activation in patients with COVID-19: A novel therapeutic target
Massimo Cugno et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19
Hao Cheng et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
Cynthia Magro et al.
TRANSLATIONAL RESEARCH (2020)
Association of Treatment Dose Anticoagulation With In-Hospital Survival Among Hospitalized Patients With COVID-19
Ishan Paranjpe et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow
Behnood Bikdeli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Hypercoagulability of COVID-19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis
Mauro Panigada et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Endothelial cell infection and endotheliitis in COVID-19
Zsuzsanna Varga et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
SARS-CoV-2 and viral sepsis: observations and hypotheses
Hui Li et al.
LANCET (2020)
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Bo Diao et al.
FRONTIERS IN IMMUNOLOGY (2020)
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
Tao Guo et al.
JAMA CARDIOLOGY (2020)
Profile of a killer: the complex biology powering the coronavirus pandemic
David Cyranoski
NATURE (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
ST-Segment Elevation in Patients with Covid-19-A Case Series
Sripal Bangalore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Targeting complement in severe coronavirus disease 2019 to address microthrombosis
Francisco Valga et al.
CLINICAL KIDNEY JOURNAL (2020)
SARS-CoV2: should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?
Gabriela M. Kuster et al.
EUROPEAN HEART JOURNAL (2020)
Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts
Luka Nicin et al.
EUROPEAN HEART JOURNAL (2020)
Interaction between Multimeric von Willebrand Factor and Complement: A Fresh Look to the Pathophysiology of Microvascular Thrombosis
Serena Bettoni et al.
JOURNAL OF IMMUNOLOGY (2017)
Cytokine storm and sepsis disease pathogenesis
Benjamin G. Chousterman et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis
D. S. Skiba et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Coronary microvascular dysfunction: an update
Filippo Crea et al.
EUROPEAN HEART JOURNAL (2014)
Infections, immunity and atherosclerosis: Pathogenic mechanisms and unsolved questions
Daniela Pedicino et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system
Robson A. S. Santos et al.
JOURNAL OF ENDOCRINOLOGY (2013)
Genetic Ace2 Deficiency Accentuates Vascular Inflammation and Atherosclerosis in the ApoE Knockout Mouse
Merlin C. Thomas et al.
CIRCULATION RESEARCH (2010)
Anti-Inflammatory Effects of the Activation of the Angiotensin-(1-7) Receptor, Mas, in Experimental Models of Arthritis
Katia Daniela da Silveira et al.
JOURNAL OF IMMUNOLOGY (2010)
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas
RAS Santos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium
G Wiemer et al.
HYPERTENSION (2002)
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction:: a systematic overview of data from individual patients
MD Flather et al.
LANCET (2000)
分享论文
